Molecular Resistance: An Early Indicator for Treatment Change?

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2011.12.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search